Johannes Czernin

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 6%percentile

0.250Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Transcriptomic Profiling of Primary Prostate Cancers and Nonlocalized Disease on Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography: A Multicenter Retrospective Study

JCO Precision Oncology(2024)10.1200/po.24.00161

Top 60%

0.250DataRank

Top 60%2 citations

Kritika Subramanian, Nimrod Barashi Gozal, Andres Ricaurte‐Fajardo, Eric V. Li, James A. Proudfoot +20 more

Papers

Driven by 20 papers — median percentile 40. Top paper: “Systemic and Tumor-directed Therapy for Oligorecurrent Metastatic Prostate Cancer (SATURN): Primary Endpoint Results from a Phase 2 Clinical Trial”.

Systemic and Tumor-directed Therapy for Oligorecurrent Metastatic Prostate Cancer (SATURN): Primary Endpoint Results from a Phase 2 Clinical Trial

European Urology(2024)10.1016/j.eururo.2024.01.021

N/A

0.961DataRank · unranked

25 citations

Matthew B. Rettig, John Shen, Robert E. Reiter, Alan Lee, Michael L. Steinberg +8 more

Transcriptomic Profiling of Primary Prostate Cancers and Nonlocalized Disease on Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography: A Multicenter Retrospective Study

JCO Precision Oncology(2024)10.1200/po.24.00161

Top 60%

0.250DataRank

Top 60%2 citations

Kritika Subramanian, Nimrod Barashi Gozal, Andres Ricaurte‐Fajardo, Eric V. Li, James A. Proudfoot +20 more

Rate of change in maximum 18F-FDOPA PET uptake and non-enhancing tumor volume predict malignant transformation and overall survival in low-grade gliomas

Journal of Neuro-Oncology(2020)10.1007/s11060-020-03407-w

N/A

0DataRank · unranked

18 citations

Jingwen Yao, Jacob Schlossman, Catalina Raymond, Matthew Ji, Hiroyuki Tatekawa +8 more

Isoquinoline thiosemicarbazone displays potent anticancer activity with in vivo efficacy against aggressive leukemias

RSC Medicinal Chemistry(2020)10.1039/c9md00594c

N/A

0DataRank · unranked

14 citations

Soumya Poddar, Roy D. Pan, Ethan W. Rosser, Evan R. Abt, Juno Van Valkenburgh +21 more

[18F]FDG PET/CT for evaluating early response to neoadjuvant chemotherapy in pediatric patients with sarcoma: a prospective single-center trial

Research Square(2020)10.21203/rs.3.rs-36997/v2

N/A

0DataRank · unranked

0 citations

Francesco Ceci, Roberto Passera, Jacquelyn Crane, Lin Du, Gang Li +8 more

FDG PET/CT for Evaluating Early Response to Neoadjuvant Chemotherapy in Pediatric Patients with Sarcoma: A Prospective Single-Center Trial

Research Square(2020)10.21203/rs.3.rs-36997/v1

N/A

0DataRank · unranked

0 citations

Francesco Ceci, Roberto Passera, Jacquelyn Crane, Lin Du, Gang Li +8 more

Safety of PSMA-Targeted Molecular Radioligand Therapy with 177Lu-PSMA-617: Results from the Prospective Multicenter Phase 2 Trial RESIST-PC (NCT03042312)

Journal of Nuclear Medicine(2021)10.2967/jnumed.121.262543

N/A

0DataRank · unranked

37 citations

Johannes Czernin, Pan Thin, J Gartmann, Kathleen Nguyen, Wesley R. Armstrong +14 more

STING-driven interferon signaling triggers metabolic alterations in pancreas cancer cells visualized by [ 18 F]FLT PET imaging

Proceedings of the National Academy of Sciences(2021)10.1073/pnas.2105390118

N/A

0DataRank · unranked

19 citations

Evan R. Abt, Thuc Le, Arthur Cho, Amanda M. Dann, Jing Cui +12 more

Reprogramming of nucleotide metabolism by interferon confers dependence on the replication stress response pathway in pancreatic cancer cells

Cell Reports(2022)10.1016/j.celrep.2021.110236

N/A

0DataRank · unranked

31 citations

Thuc Le, Amanda M. Dann, Joseph Capri, Soumya Poddar, Vincent Lok +18 more

Targeting deoxycytidine kinase improves symptoms in mouse models of multiple sclerosis

Immunology(2022)10.1111/imm.13569

N/A

0DataRank · unranked

12 citations

Jessica R. Salas, Alyssa O. Trias, Arely Perez Rodriguez, Jonathan Tsang, Miriam Güemes +11 more

18F-FDG PET Visualizes Systemic STING Agonist-Induced Lymphocyte Activation in Preclinical Models

Journal of Nuclear Medicine(2022)10.2967/jnumed.122.264121

N/A

0DataRank · unranked

9 citations

Hailey R. Lee, Evan R. Abt, Khalid Rashid, Amanda L. Creech, Keke Liang +18 more

Multivariable models of outcomes with [177Lu]Lu-PSMA-617: analysis of the phase 3 VISION trial

EClinicalMedicine(2024)10.1016/j.eclinm.2024.102862

N/A

0DataRank · unranked

26 citations

Andrei Gafita, Johann S. De Bono, Oliver Sartor, Kim N., Bernd J. Krause +11 more

Molecular Hallmarks of Prostate-specific Membrane Antigen in Treatment-naïve Prostate Cancer

European Urology(2024)10.1016/j.eururo.2024.09.005

N/A

0DataRank · unranked

14 citations

Raag Agrawal, Nicholas K. Wang, Ida Sonni, Eric V. Li, Jaron Arbet +22 more

Development of a LRRC15-Targeted Radio-Immunotheranostic Approach to Deplete Pro-tumorigenic Mechanisms and Immunotherapy Resistance

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.01.30.577289

N/A

0DataRank · unranked

3 citations

Mohamed Altai, Katharina Lückerath, Wahed Zedan, Henan Zhu, Marija Trajkovic‐Arsic +25 more

Oncologist, Business Leader, and Investor Arie S. Belldegrun Discusses a Career in Innovative Medical Entrepreneurship

Journal of Nuclear Medicine(2024)10.2967/jnumed.124.268904

N/A

0DataRank · unranked

0 citations

Ken Herrmann, Johannes Czernin, Arie S. Belldegrun

PSMA-PET/CT Findings in Patients With High-Risk Biochemically Recurrent Prostate Cancer With No Metastatic Disease by Conventional Imaging

JAMA Network Open(2025)10.1001/jamanetworkopen.2024.52971

N/A

0DataRank · unranked

61 citations

Wesley R. Armstrong, Kevyn J Clark, Matthias Benz, Clayton Smith, Loïc Djaileb +9 more

Development of a leucine-rich repeat-containing protein 15-targeted radio-immunotheranostic approach to deplete pro-tumorigenic mechanisms and immunotherapy resistance

Signal Transduction and Targeted Therapy(2025)10.1038/s41392-025-02410-9

N/A

0DataRank · unranked

3 citations

Mohamed Altai, Katharina Lückerath, Wahed Zedan, Henan Zhu, Lars Breuer +26 more

Impact of 68Ga-PSMA-11 PET on the Management of Recurrent Prostate Cancer in a Prospective Single-Arm Clinical Trial

Journal of Nuclear Medicine(2020)10.2967/jnumed.120.242180

N/A

0DataRank · unranked

117 citations

Justin Ferdinandus, Johannes Czernin, Matthias Eiber, Robert R. Flavell, Spencer C. Behr +13 more

A comparative study of preclinical and clinical molecular imaging response to EGFR inhibition using osimertinib in glioblastoma

Neuro-Oncology Advances(2025)10.1093/noajnl/vdaf022

N/A

0DataRank · unranked

1 citations

Quincy Okobi, Robert Chong, Rhea Plawat, Eva Zhao, Andrei Gafita +13 more

[18F]FDG PET/CT for evaluating early response to neoadjuvant chemotherapy in pediatric patients with sarcoma: a prospective single-center trial

EJNMMI Research(2020)10.1186/s13550-020-00715-0

N/A

0DataRank · unranked

15 citations

Francesco Ceci, Roberto Passera, Jacquelyn Crane, Lin Du, Gang Li +8 more

Johannes Czernin

Indexed papers

Top data-sharing exemplar

Papers